Clinical Trial: Evaluate of the Use of Uromune as a Potential Non-antibiotic Prophylactic Strategy for Catheter-associated Urinary Tract Infection in Patients With Long-term Catheterization.

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07869992) titled 'Evaluate of the Use of Uromune as a Potential Non-antibiotic Prophylactic Strategy for Catheter-associated Urinary Tract Infection in Patients With Long-term Catheterization.' on Oct. 06.

Brief Summary: A self-controlled pilot study to evaluate the use of oral bacterial immunotherapy for prevention of catheter-associated urinary tract infection.

Study Start Date: Oct. 30

Study Type: OBSERVATIONAL

Condition: Catheter-Associated Urinary Tract Infections (CAUTIs)

Intervention: DRUG: Uromune

Oral bacterial immunotherapy (Sublingual Vaccine Uromune) MV140

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chinese University of Hong...